Evidence map›Paper›PMID 33769943›Full record

ReviewJMIR mHealth and uHealth2021

Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review.

Elizabeth Houlding, Kedar K V Mate, Kim Engler, David Ortiz-Paredes, Marie-Pascale Pomey, Joseph Cox, Tarek Hijal, Bertrand Lebouché

Registry-linked trialAbstract readReview
In one paragraph

Review in JMIR mHealth and uHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04978233 (Use of the Opal Patient Portal Application for Daily Follow-up of People at Home With COVID-19), which is not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04978233 completednot on this map

Use of the Opal Patient Portal Application for Daily Follow-up of People at Home With COVID-19: The Opal-COVID Feasibility Study

TypeobservationalSponsorDr. Bertrand LeboucheRan2020 to 2021Enrolled50ConditionsCOVID-19Armssociodemographic and health, daily self-assessment, and feasibility of using the Opal app for COVID
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Implementation of Remote Patient Monitoring for Hypertension Management.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elizabeth HouldingChronic Viral Illness Service, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0002-7519-5063
Kedar K V MateCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0003-0027-846X
Kim EnglerCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0001-8364-7421
David Ortiz-ParedesCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0002-0431-4889
Marie-Pascale PomeyCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID 0000-0001-5180-8139
Joseph CoxChronic Viral Illness Service, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0002-7041-1556
Tarek HijalDivision of Radiation Oncology, McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0002-9341-1735
Bertrand LebouchéChronic Viral Illness Service, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC, Canada.ORCID 0000-0002-1273-9393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has acted as a catalyst for the development and adoption of a broad range of remote monitoring technologies (RMTs) in health care delivery. It is important to demonstrate how these technologies were implemented during the early stages of this pandemic to identify their application and barriers to adoption, particularly among vulnerable populations.

objectiveThe purpose of this knowledge synthesis was to present the range of RMTs used in delivering care to patients with COVID-19 and to identify perceived benefits of and barriers to their use. The review placed a special emphasis on health equity considerations.

methodsA rapid review of published research was conducted using Embase, MEDLINE, and QxMD for records published from the inception of COVID-19 (December 2019) to July 6, 2020. Synthesis involved content analysis of reported benefits of and barriers to the use of RMTs when delivering health care to patients with COVID-19, in addition to health equity considerations.

resultsOf 491 records identified, 48 publications that described 35 distinct RMTs were included in this review. RMTs included use of existing technologies (eg, videoconferencing) and development of new ones that have COVID-19-specific applications. Content analysis of perceived benefits generated 34 distinct codes describing advantages of RMTs, mapped to 10 themes overall. Further, 52 distinct codes describing barriers to use of RMTs were mapped to 18 themes. Prominent themes associated with perceived benefits included a lower burden of care (eg, for hospitals, health care practitioners; 28 records), reduced infection risk (n=33), and support for vulnerable populations (n=14). Prominent themes reflecting barriers to use of RMTs included equity-related barriers (eg, affordability of technology for users, poor internet connectivity, poor health literacy; n=16), the need for quality "best practice" guidelines for use of RMTs in clinical care (n=12), and the need for additional resources to develop and support new technologies (n=11). Overall, 23 of 48 records commented on equity characteristics that stratify health opportunities and outcomes, including general characteristics that vary over time (eg, age, comorbidities; n=17), place of residence (n=11), and socioeconomic status (n=7).

conclusionsResults of this rapid review highlight the breadth of RMTs being used to monitor and inform treatment of COVID-19, the potential benefits of using these technologies, and existing barriers to their use. Results can be used to prioritize further efforts in the implementation of RMTs (eg, developing "best practice" guidelines for use of RMTs and generating strategies to improve equitable access for marginalized populations).

Indexed as

COVID-19PandemicsHumansSARS-CoV-2TechnologyVideoconferencingasynchronous technologybarrierbenefitCOVID-19, telehealthequitymHealthmonitoringremote monitoringreviewsynchronous technologytechnology

Identifiers

PMID33769943
PMCPMC8059785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.